Expanding the repertoire of Antibody Drug Conjugate (ADC) targets with improved tumor selectivity and range of potent payloads through in-silico analysis

• Umesh Kathad ,

  Contributed equally to this work with: Umesh Kathad, Neha Biyani

  Roles Conceptualization, Data curation, Formal analysis, Methodology, Validation, Visualization, Writing – original draft, Writing – review & editing

  * E-mail: umesh@lanternpharma.com

  Affiliation Lantern Pharma Inc., Dallas, TX, United States of America

  https://orcid.org/0009-0005-2835-6556

  ⨯
• Neha Biyani ,

  Contributed equally to this work with: Umesh Kathad, Neha Biyani

  Roles Conceptualization, Formal analysis, Validation, Writing – original draft, Writing – review & editing

  Affiliation Lantern Pharma Inc., Dallas, TX, United States of America

  ⨯
• Raniero L. Peru y Colón De Portugal,

  Roles Writing – review & editing

  Affiliation Lantern Pharma Inc., Dallas, TX, United States of America

  ⨯
• Jianli Zhou,

  Roles Writing – review & editing

  Affiliation Lantern Pharma Inc., Dallas, TX, United States of America

  ⨯
• Harry Kochat,

  Roles Writing – review & editing

  Affiliation The University of Tennessee Health Science Center, Memphis, TN, United States of America

  ⨯
• Kishor Bhatia

  Roles Supervision, Writing – review & editing

  Affiliation Lantern Pharma Inc., Dallas, TX, United States of America

  ⨯